Next Article in Journal
Halogen-Substituted Derivatives of Dictyostelium Differentiation-Inducing Factor-1 Suppress Serum-Induced Cell Migration of Human Breast Cancer MDA-MB-231 Cells in Vitro
Previous Article in Journal
A Novel Kunitzin-Like Trypsin Inhibitor Isolated from Defensive Skin Secretion of Odorrana versabilis
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Biomolecules
Volume 9
Issue 7
10.3390/biom9070255
biomolecules-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Site-Specific Incorporation of Unnatural Amino Acids into Escherichia coli Recombinant Protein: Methodology Development and Recent Achievement

by
Sviatlana Smolskaya
1,* and
Yaroslav A. Andreev
1,2
1
Sechenov First Moscow State Medical University, Institute of Molecular Medicine, Trubetskaya str. 8, bld. 2, Moscow 119991, Russia
2
Shemyakin-Ovchinnikov Institute of Bioorganic Chemistry, Russian Academy of Sciences, ul. Miklukho-Maklaya 16/10, 117997 Moscow, Russia
*
Author to whom correspondence should be addressed.
Biomolecules 2019, 9(7), 255; https://doi.org/10.3390/biom9070255
Submission received: 30 May 2019 / Revised: 21 June 2019 / Accepted: 25 June 2019 / Published: 28 June 2019
(This article belongs to the Section Synthetic Biology and Bioengineering)
Browse Figures
Versions Notes

Abstract

:
More than two decades ago a general method to genetically encode noncanonical or unnatural amino acids (NAAs) with diverse physical, chemical, or biological properties in bacteria, yeast, animals and mammalian cells was developed. More than 200 NAAs have been incorporated into recombinant proteins by means of non-endogenous aminoacyl-tRNA synthetase (aa-RS)/tRNA pair, an orthogonal pair, that directs site-specific incorporation of NAA encoded by a unique codon. The most established method to genetically encode NAAs in Escherichia coli is based on the usage of the desired mutant of Methanocaldococcus janaschii tyrosyl-tRNA synthetase (MjTyrRS) and cognate suppressor tRNA. The amber codon, the least-used stop codon in E. coli, assigns NAA. Until very recently the genetic code expansion technology suffered from a low yield of targeted proteins due to both incompatibilities of orthogonal pair with host cell translational machinery and the competition of suppressor tRNA with release factor (RF) for binding to nonsense codons. Here we describe the latest progress made to enhance nonsense suppression in E. coli with the emphasis on the improved expression vectors encoding for an orthogonal aa-RA/tRNA pair, enhancement of aa-RS and suppressor tRNA efficiency, the evolution of orthogonal EF-Tu and attempts to reduce the effect of RF1.

Graphical Abstract

1. Introduction

Only twenty amino acids composing huge repertoire of proteins with the remarkably diverse structure and function are encoded by the universal genetic code of all known organisms [1] with the rare exceptions of selenocysteine being incorporated in response to the stop codon UGA [2,3] and pyrrolysine specified by the UAG codon [3,4]. Obviously, 20 amino acid building blocks are sufficient for life, but not optimal, since proteins’ natural functions are provided by chemical groups obtained through posttranslational modifications (i.e., phosphorylation, methylation, acetylation, and hydroxylation); cofactors (such as pyridoxal, thiamine, flavins, and metal ions); and, as mentioned before, by evolved novel translational machinery to incorporate either selenocysteine or pyrrolysine [5,6].
Given the important roles of proteins in biology, it is desirable to be able to rationally modify their structure and function to aid understanding of protein structure-function relationships, investigate protein-based biological processes, and generate proteins and organisms with new properties [7]. For the protein chemists, it would be ideal to use amino acids with novel chemical or spectroscopic properties, i.e., unnatural or noncanonical amino acids (NAAs) [8].
Many diverse techniques were developed for the incorporation of NAAs into proteins to introduce new functional groups apart from those found in the canonical amino acids including chemical approach based on direct modification or synthesis of the desired proteins [9,10,11], and biosynthetic methods to totally replace canonical amino acid to their close structural analogues in auxotrophic bacteria [12,13,14,15] or co-translationally incorporate NAAs into target proteins by utilizing chemically modified aminoacylated tRNA molecules for in vitro translation [16,17,18,19] or for Xenopus oocytes [20,21,22]. Although these approaches for the generation of NAA-incorporated proteins are extremely useful for altering protein structure and properties and can be applied for a large variety of NAAs, their application is limited by the selectivity and overall efficiency of the methodology.
The general methodology of the genetic code expansion is based on the reassignment of either sense or nonsense codon to encode NAA. This methodology for NAAs incorporation exploits the translational machinery of the host cell in the same manner as the canonical amino acids. More than 200 NAAs with diverse physical, chemical, or biological properties have been incorporated into proteins in vivo and in vitro in E. coli and other bacteria, yeast, animals and mammalian cells with high fidelity and efficiency by genetic code expansion [23]. Here we are focused on the description of the methodology and the recent progress in the field of E. coli genetic code expansion with the emphasis on the nonsense suppression, since to date, it is the most robust, established and demanded techniques for the recombinant protein production.

2. Expanding the Genetic Code

An ideal methodology to incorporate NAAs into recombinant proteins was considered to exploit the translational machinery of the host cell in the same manner as the canonical amino acids, enables specific changes to be precisely made in proteins directly in vivo, thus providing novel tools for understanding biology in molecular terms in the native settings. In light of the large body of knowledge about its translational machinery and the simplicity of its genetic manipulation, E. coli was chosen as the host organism to develop the general method to co-translationally incorporate NAAs in vivo.
Process of translation is the ribosome-mediated production of a polypeptide in which the amino acid sequence is specified by the nucleotide sequence of the mRNA. Nucleotides form 64 three-base codons or triplets that encode a total of 20 amino acids. Three of the 64 codons, UAG (amber), UGA (opal), and UAA (ochre), are termination codons, alternatively called stop or nonsense codons. mRNA serves as a template for the synthesis of a polypeptide chain through a tRNA adapter molecule charged with an amino acid corresponding to its anticodon. The charging of each amino acid is carried out by specific aminoacyl-tRNA synthetase (aa-RS) forming aminoacyl-tRNA (aa-tRNA). Consequently, each aa-RS is specific for its own unique amino acid substrate, and a unique set of iso-tRNAs exists for each amino acid [24,25]. Although tRNA anticodons are conserved across all organisms, aa-RSs are often species-specific; that is, aa-RSs from one species do not aminoacylate tRNAs from other species. In the first step of translation, initiation, the small ribosomal subunit (30S) is associated to an mRNA through the correct base pairing of Shine–Dalgarno sequence (SD) with 16S ribosomal RNA (rRNA). Subsequently, the initiator aminoacyl-tRNA, formylmethionine-tRNA, binds with the help of initiation factors 1 (IF1) and 2 (IF2) to the AUG start codon of mRNA that, in turn, leads to the association with the 50S ribosomal subunit with the complex. Formylmethionine-tRNA is bound to the P (peptidyl) site of the now 70S ribosome, with the second codon displayed in the available A (aminoacyl) site. The series of events is partly driven by the hydrolysis of IF2 bound GTP. During the second phase, elongation, aminoacyl-tRNA in ternary complex with elongation factor Tu (EF-Tu) and GTP binds to the A site of the 70S ribosome. Correct codon-anticodon recognition causes hydrolysis of GTP bound to EF-Tu, inducing its dissociation and the proper accommodation of the aa-tRNA into the A site. A peptide bond between the newly arrived amino acid and the formylmethionine is formed in the catalytic site of the 50S subunit formation, thereby generating a dipeptide, which is then transferred from the P-site tRNA to the amino acid on the A-site. EF-Tu is recycled by the rapid exchange of GDP to GTP, facilitated by elongation factor Ts (EF-Ts). The translocation step is facilitated by elongation factor G (EF-G) and the hydrolysis of another GTP molecule. The elongation cycle proceeds until a stop codon in the mRNA is encountered, which triggers recruitment of a class I release factor (RF1 or RF2 depending on the stop codon) to the A site of the ribosome. The RF-ribosome interaction leads to hydrolysis of the ester bond between the C-terminal amino acid of the polypeptide and the P-site tRNA, releasing the polypeptide from the ribosome. The GTP associated class II release factor 3 (RF3) then destabilizes the class I release factor and they both dissociate, leaving the 70S ribosome bound to mRNA and a now deacylated tRNA in P site. In the final step, the ribosome is split by the ribosome recycling factor (RRF) and EF-G·GTP and held apart ready for another round of protein synthesis [26] (Figure 1a).
As is the case with canonical amino acids, NAA can be incorporated by supplying organisms with a non-endogenous aa-RS/tRNA pair, referred to as an orthogonal pair that directs site-specific incorporation of NAA in response to a unique codon [6]. This aa-RS/tRNA/codon set must not crosstalk with endogenous aa-RS/tRNA/codon sets (i.e., be orthogonal) and must be functionally compatible with other components of the translation apparatus [27]. Specifically, the orthogonal tRNA should not be recognized by any endogenous synthetase and should decode the orthogonal codon, which is not assigned to any canonical amino acid. The orthogonal synthetase should not charge any endogenous tRNA but the orthogonal tRNA. In addition, the orthogonal synthetase should only charge the orthogonal tRNA with the NAA. The NAA must be metabolically stable and have good cellular bioavailability; it must be tolerated by EF-Tu and the ribosome, but it cannot be a substrate for any endogenous synthetase [5]. Once expressed in cells, the orthogonal synthetase charges the orthogonal tRNA with the desired NAA, and the acylated tRNA incorporates the attached NAA into proteins in response to the unique codon by utilizing the endogenous translational machinery [28] (Figure 1b).
A unique codon is required to specify the NAA. Initially, site-specific incorporation of NAA into a protein was based on nonsense suppression (Figure 2a) [16,29]. The term “nonsense suppression” refers to the use of nonsense codons and suppressor tRNAs, which recognize stop codons. The amber UAG stop codon has been most frequently used for the incorporation of NAAs, but the use of the ochre (UAA) stop [30,31,32] and the opal (UGA) stop codons [33,34,35] have been applied, especially for the incorporation of diverse NAAs into one recombinant protein [36,37,38,39]. The major advantage of the nonsense suppression technique lies in its simplicity. Nevertheless, even amber stop codon terminates about 320 genes in the model laboratory strain of E. coli K-12 [40,41], meaning that the NAA would be incorporated not only in the protein of interest but also in response to TAG stop codons of the genes present in the genome.
The existence of only three stop codons in the genetic code limits the theoretical number of NAAs that could be incorporated into recombinant proteins. Sisido and coworkers suggested overcoming this limitation with frameshift suppression based on the application of four- or five-base extended codon and a cognate suppressor [42,43,44]. In certain species, some naturally occurring codons are rarely used and the amount of their corresponding tRNA is low. Rarely used sense codons, such as arginine (AGG) [45,46] or proline (CCC) codons of E. coli, can be used for direct NAA incorporation in proteins [47] or for designing of extended codons and frameshift suppression (Figure 2b,c) [44]. In this approach, an mRNA containing an extended codon consisting of four or five bases is read by a modified aa-tRNA containing the corresponding extended anticodon, and a full-length protein containing NAA at the specific site is obtained. If the extended codon is read as a three-base codon by an endogenous tRNA, the reading frame will be shifted by one base that in turn leads to a premature encounter with a stop codon and early termination of protein synthesis [26].
In each case, suppression is in competition with other processes, such as RF binding to nonsense codons or recognition of frameshift codons by tRNAs with three-base anticodons, both of which lead to decreased co-translational incorporation efficiency [5].

3. Orthogonal Pairs for NAAs in E. coli

The generation of orthogonal aa-RS/tRNA pairs derived from the translation apparatus of the host organism was challenging, considering that there is already a pool of aa-RS/tRNA pairs assigned for their cognate codons presented within cells. A successful strategy was to import an aa-RS/tRNA pair from a different species. Archaeal synthetases/tRNAs have been considered as a good source of orthogonal aa-RS/tRNA pairs to apply in E. coli. One of the reasons is that although synthetases from archaea are phylogenetically closer to their eukaryotic counterparts [24,25], they can be expressed in E. coli in their active forms. Moreover, cross-species aminoacylation of archeal tRNA by E. coli synthetases has been shown to be low [48]. The first orthogonal aa-RS/tRNA pair in E. coli generated from archaeal bacteria was derived from the tyrosyl-tRNA synthetase (TyrRS)/tRNATyr from Methanocaldococcus jannaschii [49]. It was known that amber stop codon was the least used codon and the presence of natural amber suppressors in some E. coli strains did not significantly affect cell-growth rates [50,51], hence, amber was initially applied to specify the NAA. Additionally, chemically aminoacylated amber suppressor has been used for the in vitro introduction of NAAs into proteins in E. coli-based cell-free system [52]. M. jannaschii tRNATyr recognition elements include bases A73 and C1-G72 in the acceptor stem, while the anticodon triplet participates only weakly in identity determination [53]. Since E. coli tRNATyr identity determination pattern differs from that of M. jannaschii and additionally includes a long variable arm, and the anticodon as identity elements, MjtRNATyr was considered to be a good candidate for the orthogonal suppressor. Additionally, MjTyrRS has a minimalist anticodon-loop-binding domain [54], which made it possible to alter the anticodon loop of MjtRNATyr to CUA with a relatively low reduction in its affinity for the synthetase [6]. Finally, MjTyrRS does not have an editing mechanism that could deacylate the NAA [55]. The M. jannaschii tRNATyrCUA (MjtRNATyrCUA) with mutated anticodon for recognizing the amber codon UAG and its cognate MjTyrRS functioned efficiently in translation in E. coli, but there was a small degree of aminoacylation of this MjtRNATyrCUA by endogenous E. coli synthetases [49].
To improve the orthogonality of MjtRNATyrCUA a general strategy was developed, consisting of a combination of negative and positive selections with a library of tRNA mutants in the absence and presence of the cognate synthetase, respectively [56]. Firstly, 11 nucleotides that do not interact directly with MjTyrRS were randomly mutated to generate a suppressor-tRNA library. Then suppressors were expressed in E. coli along with a toxic ribonuclease barnase gene, with amber nonsense codons introduced into the permissive sites. MjtRNATyrCUA variants which were substrates for endogenous E. coli aa-RSs (i.e., were not orthogonal) were removed from the library by suppression of amber nonsense mutations in the barnase gene, resulting in cell death. All tRNAs from surviving clones were then subjected to a positive selection in the presence of the cognate heterologous synthetase and a β-lactamase gene with an amber codon at a permissive site. An orthogonal variant of MjtRNATyrCUA was selected on the basis of its ability to be aminoacylated by its cognate MjTyrRS and to suppress the amber codon to confer ampicillin resistance [6,57]. Therefore, selected MjtRNATyrCUA suppressor was not a substrate for the endogenous E. coli synthetase, but only for its cognate MjTyrRS; and it functioned efficiently in translation.
A similar two-step selection scheme was then used to alter the specificity of the orthogonal synthetase to charge its cognate MjtRNATyrCUA suppressor with unique NAA of interest and none of the canonical amino acids. First, a library of aa-RS mutants containing randomized residues in the amino acid-binding site was constructed on the basis of available crystal structures [58,59]. This library was transformed into E. coli cells that express tRNACUA and a gene encoding chloramphenicol acetyltransferase (CAT) with a stop codon mutation at a permissive site. In this positive selection step, these cells were grown in the presence of chloramphenicol and the NAA of interest so that only the aa-RS mutants capable of aminoacylating tRNACUA with the NAA and/or endogenous amino acids survived. Surviving mutants were then transformed into E. coli cells that express tRNACUA and the toxic barnase gene with stop codon mutations at permissive. In this negative selection step, cells were grown in the absence of the NAA so that all clones whose mutant aa-RS aminoacylates endogenous amino acids died. Only mutant aa-RSs that aminoacylate tRNACUA with the NAA left. The two-step selection is usually repeated for two to three additional rounds to yield NAA-specific mutant aa-RS. This two-step selection scheme was applied for the identification of mutant orthogonal TyrRS/tRNAtyr pairs with altered substrate specificity. M. jannaschii synthetase/tRNA pairs characterized by excellent fidelity have been applied for incorporation of chemically distinct NAAs into recombinant proteins of E. coli [5], Salmonella [60], Streptomyces venezuelae ATCC 15439 [61] and Mycobacterium tuberculosis [62].
Nevertheless, the ability to encode novel NAAs is determined and limited by the structure of the synthetase active site. In order to expand the repertoire and diversity of NAAs, several additional orthogonal pairs have been adapted for application in E. coli. These pairs include some derived from archaea, such as a lysine-RS/tRNALys pair from Pyrococcus horikoshii [63], a glutamine-RS/tRNAGlu pair from Methanosarcina mazei [64], pyrrolysine-RS/tRNAPyl pair from Methanosarcina species [65,66,67]; as well as a heterologous pair consisting of a leucyl-tRNA synthetase from Methanobacterium thermoautotrophicum and a mutant tRNALeu derived from Halobacterium sp. [34], and pair consisting of P. horikoshii proline-RS and three engineered suppressors tRNAPro from Archaeoglobus fulgidus [68].

3.1. Optimized Orthogonal Translation System for NAA Incorporation into Recombinant Proteins in E. coli

Nowadays, genetic code expansion in E. coli using the amber suppression strategy and evolved variants of orthogonal M. jannaschii TyrRS/MjtRNATyrCUA is considered to be the most established and robust methodology to site-specifically incorporate NAAs. However, the number of NAA-incorporated proteins obtained with orthogonal M. jannaschii aa-RS/MjtRNA pairs in vivo is considerably lower in comparison to the wild type. One of the reasons for the low yields of NAA-incorporated protein in the nonsense suppression studies is that both orthogonal synthetase and its suppressor tRNA are transferred into the host organisms and presented in the ratio that is not optimal for the efficient functioning in the translational process. The most fundamental improvements were based on the development of the vector system for the optimal expression of recombinant proteins. The significant increase in NAA-containing protein yield was achieved by the replacement of two plasmids, each one encoding either synthetase or suppressor tRNA, to the single-plasmid system pSup-MjTyrRS-6TRN [69]. The plasmid backbone belongs to the most popular expression ColE1-like plasmid vectors [70] with a mid-copy-number to low-copy-number p15A origin that makes it compatible with most of the vectors designed for protein expression in E. coli background. The designed pSup-MjTyrRS-6TRN vector allowed increasing the NAA-containing protein yield due to the number of regulatory elements modification: Firstly, the amber suppressor tRNA is expressed under regulation of naturally occurring E. coli prolyl-tRNA promoter and terminator (proK), the plasmid encodes six copies of MjtRNATyrCUA in two polycistronic operons; secondly, E. coli glutaminyl-tRNA synthetase promoter (glnS) regulating expression of the orthogonal variants of M. jannaschii TyrRS was mutated to glnS’ promoter [71]; finally, the single mutation D286R was introduced in the sequence of MjTyrRS and its derivatives that led to the enhanced recognition of anticodon of MjtRNATyrCUA suppressor [58]. The yield of purified NAA-incorporated proteins obtained due to the application of pSup-MjTyrRS-6TRN plasmid system has been reported to reach 40 mg/L.
The plasmid vector pEVOL was reported to afford enhanced NAA incorporation into recombinant proteins in comparison with pSup-MjTyrRS-6TRN. It is known that suppression efficiency depends greatly on the degree of orthogonal tRNA compatibility with the translational apparatus of the host cell. The reasons for such an incompatibility are the low affinity of E. coli EF-Tu to NAA-charged MjtRNACUA derived from archeal tRNATyr [72] or its inability to recognize and deliver orthogonal tRNA to ribosomal A-site [73]. A number of genetic, biochemical, and structural studies have implicated specific residues within the tRNA acceptor stem and T stem as being important for EF-Tu binding [72]. Directed evolution experiments revealed that GC-rich T-stem of MjtRNA allowed identifying the modified suppressor tRNACUAopt that increased NAA incorporation efficiency due to enhanced affinity to EF-Tu of E. coli [74]. The higher yield of mutant protein obtained with the use of the plasmid pEVOL was achieved through the application of the T-stem modified suppressor tRNACUAOpt expressed under the regulation of proK promoter combining with the use of both constitutive (glnS’) and arabinose-inducible (araBAD) promoters to drive the transcription of two copies of the M. jannaschii aa-RS gene. Hence, yields were further increased to 100 mg/L and were around 250% greater than the previously developed pSup-MjTyrRS-6TRN system, ranging from roughly 35% to 50% of wild-type protein for most mutant aa-RS/tRNA pairs [75].
An important role of orthogonal tRNA modification for overall suppression efficiency was further demonstrated [76] by the evolution of MjtRNACys with altered anticodon-flanking regions for phosphoserine incorporation. The library of suppressor tRNAs molecules with random nucleotide combination in G29-U33 and G37-C41 that flank the anticodon was subjected to the selection pressure. The application of selected variants MjtRNACys with enhanced suppression efficiency in combination with evolved Methanococcus maripaludis SepRS with modified anticodon binding domain enabled site-specific incorporation of phosphoserine into recombinant proteins. Although the progenitor orthogonal pair consisting of M. maripaludis SepRS and MjtRNACys enabled NAAs incorporation only in the presence of evolved EF-Tu [73], several evolved MjtRNACys variants did not require EF-Tu modification.
Further enhancement of the yield of recombinant proteins with site-specifically incorporated single or multiple NAA was achieved by the application of pUltra plasmid due to plasmid backbone and regulatory elements substitutions [77]. In contrast with pSup-MjTyrRS-6TRN and pEVOL vector systems, this one utilizes pCDF-1b plasmid backbone with the CloDF13 replicon (cdf), spectinomycin resistance cassette and lacI-regulatory elements. The application of the high-copy-number cdf origin of replication provided higher expression level of orthogonal pair. On the other hand, cdf is a rare ori [78] that in combination with spectinomycin resistance cassette made pUltra compatible with another commonly used plasmids. The pUltra plasmid encoded one copy of M. jannaschii aa-RS under the regulation of hybrid tacI promoter inducible by IPTG, the coding sequence of aa-RS was flanked by a strong ribosome binding site sequence (AAGGAG) and rrnB transcription-termination sequence from pEVOL plasmid at 5′- and 3′-ends, respectively. In similarity with pEVOL plasmid, a single copy of optimized tRNACUAOpt under the regulation of proK promoter was used in pUltra plasmid. The application of developed plasmid provided faster expression kinetic and higher suppression efficiency (20%–50% and 200%–300% higher for the suppression of 1 and 3 amber stop codon, respectively, compared with the pEVOL). This plasmid was shown to be useful for the expression of weak orthogonal pairs [68] for the enhanced ochre nonsense suppression by optimized Methanosarcina PylRS/tRNAPyl pair and for the efficient incorporation of two distinct NAAs applying different orthogonal aa-RS/tRNA pairs for amber and ochre suppression encoded in the same plasmid [77].
However, the replacement of multiple copies of M. jannaschii orthogonal synthetase to the single copy inserted into bacterial chromosome demonstrated [79] that evolved aa-RS was an inefficient enzyme and, hence, an improved suppression efficiency achieved by applying pEVOL and pUltra plasmid was based on the enhanced level of orthogonal pairs expression or multiplication of gene copies number in expression vector. Very recently, the efficiency of NAA incorporation by M. jannaschii orthogonal MjTyrRS/MjtRNATyrCUA pair and its derivatives in response to stop codon was enhanced by further evolution of orthogonal synthetase to improve the catalytic activity toward cognate NAAs. Since the anticodon of M. jannaschii tyrosine-tRNA was altered from GUA to CUA, the MjTyrRS recognition of MjtRNATyrCUA became less effective. Guo et al. [80] applied a directed evolution approach. Briefly, the thorough analysis of the crystal structure of MjTyrRS revealed four amino acids residues (Phe261, His283, Met285, and Asp286) in anticodon recognition pocket responsible for interaction with MjtRNATyrCUA; these amino acids were randomly mutated by means of overlapping PCR and the resulting aa-RS library was subjected to two or three rounds of positive-negative selection. The positive selection revealed functional synthetase by their ability to suppress stop codon in CAT Asp112Stop in the presence of NAA, while the negative selection in the absence of NAA eliminated non-specific aa-RS charging suppressor tRNA by canonical amino acids leading to the expression of toxic barnase gene with amber stop codon at permissive sites. The direct evolution approach was successfully used to select improved variants of mutated M. jannaschii p-acetyl-L-phenylalanyl-tRNA-synthetase (AcRS) [81], p-benzoyl-L-phenylalanyl-tRNA-synthetase (BpaRS) [82], and sulfotyrosyl-tRNA-synthetase (sTyrRS) [83]. The evolved variants of M. jannaschii orthogonal synthetases demonstrated a similar pattern of mutation, however, the mutation combination differed for every aa-RSs. The observed improvement resulted from more efficient aminoacylation of MjtRNATyrCUA by the evolved MjTyrRS mutants. Another approach to improve the enzyme activity of M. jannaschii orthogonal synthetase was suggested by Amiram et al. [79]. First, genes encoding for the orthogonal AcFRS/tRNACUAOpt system [75] and four amber codon-containing TolC membrane channel for colicin ColE1 translocation were integrated into the intergenic region of the bacterial chromosome. Resulting organisms were used for the generation of aa-RSs library by diversification by multiplex automated genome engineering (MAGE) [84] using single-stranded DNA (ssDNA) pool designed for the mutagenesis of selected amino acids. Obtained diversified cell pool was subjected for the negative selection in the presence of colicin Col E1 to eliminate not orthogonal aa-RS; the remaining orthogonal AcFRS library went through the positive selection in the presence of NAA to isolate variants with improved enzyme efficiency. This approach was used to generate mutated synthetases with improved amino acid binding pocket and modified tRNA binding interface. The suppression efficiency of generated variants of AcFRS varied and was estimated to be 5-25-fold higher compared with the progenitor enzyme, and enhanced enzyme efficiency allowed incorporation of 30 NAAs in the elastin-like peptide, ELP. Notably, that described methodology was also applied for the evolution of aa-RS variants with tunable specificity allowing for the incorporation of 14 NAA. Another alternative to the traditional directed evolution approach that enables fast production of highly effective and selective orthogonal aa-RS is based on phage-assisted continuous evolution PACE selection [85]. PACE technology utilizes mutagenesis plasmids encoding for the variety of genes affecting replication fidelity that provides high mutagenesis efficiency and broad mutational spectrum [86]. Improved variants of aa-RS were selected by their ability to suppress amber stop codon at permissive positions of T7 RNA polymerase, and bacteriophage protein III, which is required for phage infections, or a dominant-negative variant of protein III as a basis for the positive and negative selection, respectively. PACE application enables to combine positive and negative selection steps since there is no need for plasmids isolation; thus only 48 h required for the evolution of improved variant of M. jannaschii polyspecific orthogonal synthetase. The highly effective chimeric Methanosarcina spp. pylRS selected by PACE demonstrated 45-fold higher enzymatic activity compared to progenitor enzymes.
In addition to the optimization of vector systems and orthogonal synthetase/tRNA themselves, the EF-Tu factor can be mutated for the better recognition of suppressor tRNA charged with NAAs. Although different tRNAs aminoacylated by their cognate natural amino acids have a comparable affinity to EF-Tu, the efficiency of EF-Tu binding is lower for mis-acylated tRNAs, as well as for the suppressor tRNAs charged with NAAs [72]. It was possible to enhance the affinity of E. coli EF-Tu to NAAs with large side chain by means of enlarging the aminoacyl-binding pocket. The application of EF-Tu mutated variants in an E. coli-base in vitro translation system allowed increased efficiency of NAA incorporation with a large aromatic side chain or altered backbones [87,88]. The strategy to enlarge binding pocket of EF-Tu based on the substitution of 10 amino acids to smaller alanine followed by the screening of most efficient mutant was applied [89]: The selected variant of mutated EF-Tu (S65A, D216A, and V274A) demonstrated 4-fold improvement in suppression efficiency. The orthogonal tRNA aminoacylated by negatively charged NAAs, such as NAAs with a phosphate group, cannot be bound and effectively transported by E. coli EF-Tu. An evolved by random mutagenesis variant of EF-Tu with altered binding pocket was applied for in vivo incorporation of phosphoserine along with orthogonal heterologous pair consisting of M. maripaludis SepRS and MjtRNACys [73]. Another mutant of EF-Tu with substitution of E216V, D217G, F219G amino acids in the binding pocket was rationally designed and successfully applied for the efficient incorporation of O-phosphotyrosine alongside with selected mutant of M. jannaschii TyrRS and tRNATyrCUA [90].
Another successful strategy for the suppression efficiency enhancement was based on the creation of orthogonal ribosome/mRNA pairs in E. coli. This orthogonal ribosome (o-ribosome)/orthogonal mRNA (o-mRNA) pair was selected and introduced into the E. coli host organism. Since the SD sequence of mRNA along with the compliment anti-Shine-Dalgarno (ASD) sequence of 16S rRNA of ribosome is mutated, this pair functions in parallel with, but independent of the endogenous ribosome/mRNA pairs, i.e., o-ribosome exclusively translates the orthogonal mRNA, and the orthogonal mRNA is not a substrate for cellular ribosomes [91]. The evolved o-ribosome was applied to develop modified A-site of 30S ribosome enabling more efficient NAAs incorporation in response to AUG (ribo-X) [92] and AUG [93] stop codon, frame-shift AAGA and AGGA codons (ribo-Q) [66]. The P-site of 50S ribosome was also modified. Following several rounds of random mutagenesis and selection obtained the 23S rRNA that was applied for in vitro incorporation of D- [94] and β-amino acids [95,96]. Another orthogonal 23S rRNA was developed for efficient recognition of the 3′-terminal end of orthogonal tRNA [97]. Due to the continuous association-dissociation reaction of ribosomal subunits, it was not possible to combine evolved 16S and 23S subunits to additionally enhance the efficiency of NAAs incorporation. However, very recently the orthogonal ribosome technology stopped to be limited by only 30S or 50S subunit of ribosome due to the construction of the tethered [98] and stapled [99] ribosome with linked 16S and 23S rRNA.

3.2. Enhancing suppression efficiency by RF1 level manipulation

One of the most important factors affecting suppression efficiency is the competition between suppressor tRNA with RF for binding to the stop codons. Prokaryotic RF functionality depends on the particular stop codon encoded in the mRNA sequence, i.e., RF1 is specific for UAA/UAG, and RF2 is specific for UAA/UGA [100]. Different approaches have been described to increase suppression efficiency of amber suppressor tRNAs via manipulation of RF1 activity, such as the use of E. coli strains with thermosensitive RF1 variants [101] and RF1-depleted E. coli strains [102,103]. Unfortunately, the prfA gene encoding the RF1 is essential for survival; hence, prfA gene deletion, which encodes RF1, was reported to be lethal in E. coli [104]. However, significant progress was made recently towards diminishing the competition with RF1 by either evolution of orthogonal ribosome or by new approaches to RF1 deletions.
One of the methodologies to enhance the incorporation of NAAs in vivo by minimizing the effects of RF1 relies on selective binding of suppressor tRNA by ribosomal A-site. As it is mentioned above, the o-ribosome)/o-mRNA pair was developed for efficient NAA-containing protein expression [91]. Next, this o-ribosome was used for the creation of the library with random mutations in the 530 loop of the decoding centre of 16S rRNA and selection of mutant with an enhanced ability to decode UAG stop codon on o-mRNA with orthogonal suppressor tRNA [92]. This evolved orthogonal ribosome (ribo-X) facilitates site-specific NAAs incorporation in response to amber stop codon by decreasing RF1 binding.
Although the total removal of the prfA gene was known to be lethal for E. coli cells, the idea of creating RF1-deficient strains with an enhanced ability for site-specific NAA incorporation was very attractive. The early progress was based on the construction of E. coli strains with a temperature-sensitive RF1, which was almost completely inactive at 37 °C [104,105]. These mutants were characterized by increased efficiency of the amber tRNA suppressor, although the overall protein synthesis was low in these systems. Another improved E. coli strain for NAA incorporation was obtained by knocking-out prfA gene combined with altering or “fixing” RF2 function using MDS42 [106] as the parental strain, in which the genome had been minimized through the removal of nearly 700 nonessential genes [103]. RF2 mutation T246A allowed it to be expressed constitutively in the host cell background and to increase the affinity of RF2 toward UAA codons, while A293E mutation almost completely rescued growth rate in RF1 knocked-out strain JX33 by weak termination of UAG stop codon [107]. The obtained JX33 strain was used for efficient incorporation of NAAs in response to multiple TAG sites. The partial and total genome reassignment was also applied for the creation of RF1-deleted strains. Seven essential E. coli genes (coaD, hda, hemA, mreC, murF, lolA, and lpxK) are terminated by amber codons. ORFs of all seven of these genes were engineered to end with the TAA stop codon, placed on a bacterial artificial chromosome (BAC), and the resulting BAC7 plasmid was introduced into an E. coli strain containing an amber suppressor tRNA. The prfA gene was then knocked out in these strains [108], which required the presence of both the amber suppressor and the BAC7 plasmid. Although the obtained strain was characterized by a slower growth rate, this RF1 knockout system was used for the incorporation of 3-iodo-L-tyrosine in response to seven amber codons. Similarly, the TAA termination codons were introduced into the end of seven essential genes by replacement of their genomic copies followed by an RF1 knockout [109]. Although the RF1 knockout in the resulting strain EcAR7 causes a decrease in the growth rate, it prevents premature stopping at the TAG codon and improves yields of phosphoprotein production. The B strain of E. coli, such as BL21(DE3), are widely used for the expression of recombinant protein under the T7-promoter regulation. The genome of BL21(DE3) contains 273 genes, including 95 essentials for growth of bacterial cells, are terminated by TAG stop codon. Using oligonucleotide-mediated recombination approach Mukai et al. replaced all 95 TAG codons on TAA or TGA stop signals and knocked out the prfA gene. The obtained B-95.ΔA strain demonstrated high efficiency in NAA-incorporated recombinant protein production without any attenuation in cell growth [110]. Finally, a new strain C321.ΔRF1 was evolved by replacement of all 321 known TAG stop codons in E. coli MG1655 with synonymous TAA codons, which permitted the deletion of RF1 and reassignment of TAG translation function. This genomically recoded organism (GRO) exhibited improved properties for the incorporation of NAAs in response to amber stop codon without any deleterious effect on the cellular functions [111]. The C321.ΔRF1 strain was demonstrated to be particularly useful for the multi-site incorporation of diverse NAAs [112].
The summary of recently developed techniques applied to enhance efficiency of the genetic code expansion is illustrated by Figure 3.

4. Conclusions

The last decade was characterized by significant progress in the orthogonal translational system comprehension. Recent efforts in orthogonal translation systems improvement combined with the application of genetically recoded organisms allowed to improve the overall efficiency of methodology and to produce a recombinant protein with single or multiple site-specifically incorporated NAA with the yield equal or comparable with wild type protein synthesis. The intensive studies of the expanded genetic code methodology allowed not only for the development of highly effective tools for the protein molecular imaging, site-specific labelling, production of biomaterials or therapeutical peptide with improved and new properties [113], but also revealed that many other aspects must be considered as a potential limiting factor for the efficient NAA incorporation into recombinant proteins. For instance, the NAAs with bulky or extremely charged chemical group are unable to effectively cross cellular membrane, thus, the successful approach to evolve orthogonal pairs and site-specifically incorporate such a NAAs would be either propeptide strategy utilizing NAAs in dipeptide form [114] or modification of the host organism transport system, such as engineering of periplasmic binding protein, for optimized uptake of the desired NAA into the cell [115]. Very recently the significance of heterologous cellular background, particularly the enzymes modifying the orthogonal tRNA, for NAA-containing protein synthesis was demonstrated [116]. Another important issue to consider is the permissivity of the mutation site, i.e., sequence flexibility representing an ability to tolerate a large number of mutations at a selected locus without significant loss in protein activity [117]. The efficiency of NAA incorporation in response to a stop codon is known to depend on the position of the mutation site and the nature of the recombinant protein and the context dependence. The thorough analysis demonstrated [118] that mRNA, operon, and cellular context effects define the permissivity of the site for the NAAs incorporation.
Despite the progress made in the NAAs incorporation field, it still has lots of challenges to be addressed in future investigation. For instance, although the repertoire of NAAs has been greatly extended, their diversity is still limited by the very few core structures defined mainly by the substrate specificity of evolved orthogonal synthetase. The proposed new approaches for the evolution of orthogonal pairs [79] and enhancement of their enzymatic activity [89] could be considered as a perspective to produce new orthogonal translation systems from other organisms and kingdoms that, in turn, can greatly increase the number and diversity of NAAs incorporation. Another challenging issue is the incorporation of multiple diverse NAAs in the same peptide or protein since they must be assigned by the different unique codons. This problem can be only partially overcome by the application of the frameshift suppression technique. However, the application of unnatural nucleotides and semi-synthetic organisms with two additional complement bases [119] made the number of codons assigned for the different NAAs is almost unlimited.
To summarize, the efficacy and the robustness the genetic code expansion methodology provides great opportunities in protein engineering both for the fundamental researches and for the applied biotechnology. Considering recent achievements and perspectives it might become the most powerful tool for the great area of application in protein science.

Author Contributions

Writing—original draft preparation, S.S.; writing—review and editing, Y.A.A.

Funding

This work was funded by the Russian Science Foundation (grant No. 16-15-00167).

Acknowledgments

The authors acknowledge the Russian Science Foundation. S.S. acknowledges Prof. L. Alfonta. Anonymous reviewers are thanked for critically reading the manuscript and suggesting substantial improvements.

Conflicts of Interest

The authors declare no conflict of interest.

References

  1. Magliery, T.J. Unnatural protein engineering: Producing proteins with unnatural amino acids. Med. Chem. Rev. Online 2005, 2, 303–323. [Google Scholar] [CrossRef]
  2. Böck, A.; Forchhammer, K.; Heider, J.; Leinfelder, W.; Sawers, G.; Veprek, B.; Zinoni, F. Selenocysteine: The 21st amino acid. Mol. Microbiol. 1991, 5, 515–520. [Google Scholar] [CrossRef] [PubMed]
  3. Polycarpo, C.; Ambrogelly, A.; Ruan, B.; Tumbula-Hansen, D.; Ataide, S.F.; Ishitani, R.; Yokoyama, S.; Nureki, O.; Ibba, M.; Söll, D. Activation of the pyrrolysine suppressor tRNA requires formation of a ternary complex with class I and class II lysyl-tRNA synthetases. Mol. Cell 2003, 12, 287–294. [Google Scholar] [CrossRef]
  4. Srinivasan, G.; James, C.M.; Krzycki, J.A. Pyrrolysine encoded by UAG in Archaea: Charging of a UAG-decoding specialized tRNA. Science 2002, 296, 1459–1462. [Google Scholar] [CrossRef] [PubMed]
  5. Liu, C.C.; Schultz, P.G. Adding new chemistries to the genetic code. Annu. Rev. Biochem. 2010, 79, 413–444. [Google Scholar] [CrossRef] [PubMed]
  6. Xie, J.; Schultz, P.G. A chemical toolkit for proteins—An expanded genetic code. Nat. Rev. Mol. Cell Biol. 2006, 7, 775–782. [Google Scholar] [CrossRef] [PubMed]
  7. Wang, L.; Schultz, P.G. Expanding the genetic code. Angew. Chem. Int. Ed. Engl. 2004, 44, 34–66. [Google Scholar] [CrossRef] [PubMed]
  8. Furter, R. Expansion of the genetic code: Site-directed p-fluoro-phenylalanine incorporation in Escherichia coli. Protein Sci. 1998, 7, 419–426. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  9. Hendrickson, T.L.; Crécy-Lagard, V.D.; Schimmel, P. Incorporation of nonnatural amino acids into proteins. Annu. Rev. Biochem. 2004, 73, 147–176. [Google Scholar] [CrossRef] [PubMed]
  10. Adusumalli, S.R.; Rawale, D.G.; Singh, U.; Tripathi, P.; Paul, R.; Kalra, N.; Mishra, R.K.; Shukla, S.; Rai, V. Single-Site Labeling of Native Proteins Enabled by a Chemoselective and Site-Selective Chemical Technology. J. Am. Chem. Soc. 2018, 140, 15114–15123. [Google Scholar] [CrossRef] [PubMed]
  11. Matos, M.J.; Oliveira, B.L.; Martinez-Saez, N.; Guerreiro, A.; Cal, P.M.S.D.; Bertoldo, J.; Maneiro, M.; Perkins, E.; Howard, J.; Deery, M.J.; et al. Chemo-and Regioselective Lysine Modification on Native Proteins. J. Am. Chem. Soc. 2018, 140, 4004–4017. [Google Scholar] [CrossRef] [PubMed]
  12. Cohen, G.N.; Cowie, D.B. Total replacement of methionine by selenomethionine in the proteins of Escherichia coli. C. R. Hebd. Seances Acad. Sci. 1957, 244, 680–683. [Google Scholar] [PubMed]
  13. Lepthien, S.; Hoesl, M.G.; Merkel, L.; Budisa, N. Azatryptophans endow proteins with intrinsic blue fluorescence. Proc. Natl. Acad. Sci. USA 2008, 105, 16095–16100. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  14. Budisa, N.; Rubini, M.; Bae, J.H.; Weyher, E.; Wenger, W.; Golbik, R.; Huber, R.; Moroder, L. Global replacement of tryptophan with aminotryptophans generates non-invasive protein-based optical pH sensors. Angew. Chem. Int. Ed. Engl. 2002, 41, 4066–4069. [Google Scholar] [CrossRef]
  15. Van Hest, J.C.M.; Kiick, K.L.; Tirrell, D.A. Efficient Incorporation of Unsaturated Methionine Analogues into Proteins in Vivo. J. Am. Chem. Soc. 2000, 122, 1282–1288. [Google Scholar] [CrossRef]
  16. Noren, C.; Anthony-Cahill, S.; Griffith, M.; Schultz, P. A general method for site-specific incorporation of unnatural amino acids into proteins. Science 1989, 244, 182–188. [Google Scholar] [CrossRef] [PubMed]
  17. Johnson, A.E.; Woodward, W.R.; Herbert, E.; Menninger, J.R. N, iε-Acetyllysine transfer ribonucleic acid: A biologically active analogue of aminoacyl transfer ribonucleic acids. Biochemistry 1976, 15, 569–575. [Google Scholar] [CrossRef]
  18. Ye, S.; Ann Berger, A.; Petzold, D.; Reimann, O.; Matt, B.; Koksch, B. Chemical aminoacylation of tRNAs with fluorinated amino acids for in vitro protein mutagenesis. Beilstein J. Org. Chem. 2010, 6, 40. [Google Scholar] [CrossRef]
  19. Fujino, T.; Goto, Y.; Suga, H.; Murakami, H. Ribosomal Synthesis of Peptides with Multiple β-Amino Acids. J. Am. Chem. Soc. 2016, 138, 1962–1969. [Google Scholar] [CrossRef]
  20. Saks, M.E.; Sampson, J.R.; Nowak, M.W.; Kearney, P.C.; Du, F.; Abelson, J.N.; Lester, H.A.; Dougherty, D.A. An engineered Tetrahymena tRNAGln for in vivo incorporation of unnatural amino acids into proteins by nonsense suppression. J. Biol. Chem. 1996, 271, 23169–23175. [Google Scholar] [CrossRef]
  21. Nowak, M.W.; Kearney, P.C.; Sampson, J.R.; Saks, M.E.; Labarca, C.G.; Silverman, S.K.; Zhong, W.; Thorson, J.; Abelson, J.N.; Davidson, N. Nicotinic receptor binding site probed with unnatural amino acid incorporation in intact cells. Science 1995, 268, 439–442. [Google Scholar] [CrossRef] [PubMed]
  22. Dougherty, D.A.; Van Arnam, E.B. In vivo incorporation of non-canonical amino acids by using the chemical aminoacylation strategy: A broadly applicable mechanistic tool. Chembiochem 2014, 15, 1710–1720. [Google Scholar] [CrossRef] [PubMed]
  23. Vargas-Rodriguez, O.; Sevostyanova, A.; Soll, D.; Crnkovic, A. Upgrading aminoacyl-tRNA synthetases for genetic code expansion. Curr. Opin. Chem. Biol. 2018, 46, 115–122. [Google Scholar] [CrossRef] [PubMed]
  24. Ibba, M.; Soll, D. Aminoacyl-tRNA synthesis. Annu. Rev. Biochem. 2000, 69, 617–650. [Google Scholar] [CrossRef] [PubMed]
  25. Ibba, M.; Soll, D. The renaissance of aminoacyl-tRNA synthesis. EMBO Rep. 2001, 2, 382–387. [Google Scholar] [CrossRef]
  26. Stromgaard, A.; Jensen, A.A.; Stromgaard, K. Site-specific incorporation of unnatural amino acids into proteins. Chembiochem 2004, 5, 909–916. [Google Scholar] [CrossRef] [PubMed]
  27. Liu, D.R.; Schultz, P.G. Progress toward the evolution of an organism with an expanded genetic code. Proc. Natl. Acad. Sci. USA 1999, 96, 4780–4785. [Google Scholar] [CrossRef] [Green Version]
  28. Wang, Q.; Parrish, A.R.; Wang, L. Expanding the genetic code for biological studies. Chem. Biol. 2009, 16, 323–336. [Google Scholar] [CrossRef]
  29. Bain, J.D.; Diala, E.S.; Glabe, C.G.; Dix, T.A.; Chamberlin, A.R. Biosynthetic site-specific incorporation of a non-natural amino acid into a polypeptide. J. Am. Chem. Soc. 1989, 111, 8013–8014. [Google Scholar] [CrossRef]
  30. Kohrer, C.; Xie, L.; Kellerer, S.; Varshney, U.; RajBhandary, U.L. Import of amber and ochre suppressor tRNAs into mammalian cells: A general approach to site-specific insertion of amino acid analogues into proteins. Proc. Natl. Acad. Sci. USA 2001, 98, 14310–14315. [Google Scholar] [CrossRef] [Green Version]
  31. Kohrer, C.; Yoo, J.H.; Bennett, M.; Schaack, J.; RajBhandary, U.L. A possible approach to site-specific insertion of two different unnatural amino acids into proteins in mammalian cells via nonsense suppression. Chem. Biol. 2003, 10, 1095–1102. [Google Scholar] [CrossRef] [PubMed]
  32. Wan, W.; Huang, Y.; Wang, Z.; Russell, W.K.; Pai, P.; Russell, D.H.; Liu, W.R. A facile system for genetic incorporation of two different noncanonical amino acids into one protein in Escherichia coli. Angew. Chem. Int. Ed. 2010, 49, 3211–3214. [Google Scholar] [CrossRef] [PubMed]
  33. Capone, J.P.; Sedivy, J.M.; Sharp, P.A.; RajBhandary, U.L. Introduction of UAG, UAA, and UGA nonsense mutations at a specific site in the Escherichia coli chloramphenicol acetyltransferase gene: Use in measurement of amber, ochre, and opal suppression in mammalian cells. Mol. Cell. Biol. 1986, 6, 3059–3067. [Google Scholar] [CrossRef] [PubMed]
  34. Anderson, J.C.; Schultz, P.G. Adaptation of an orthogonal archaeal leucyl-tRNA and synthetase pair for four-base, amber, and opal suppression. Biochemistry 2003, 42, 9598–9608. [Google Scholar] [CrossRef]
  35. Zhang, Z.; Alfonta, L.; Tian, F.; Bursulaya, B.; Uryu, S.; King, D.S.; Schultz, P.G. Selective incorporation of 5-hydroxytryptophan into proteins in mammalian cells. Proc. Natl. Acad. Sci. USA 2004, 101, 8882–8887. [Google Scholar] [CrossRef] [Green Version]
  36. Kim, J.; Seo, M.; Lee, S.; Cho, K.; Yang, A.; Woo, K.; Kim, H.; Park, H. Simple and Efficient Strategy for Site-Specific Dual Labeling of Proteins for Single-Molecule Fluorescence Resonance Energy Transfer Analysis. Anal. Chem. 2013, 85, 1468–1474. [Google Scholar] [CrossRef]
  37. Ozer, E.; Chemla, Y.; Schlesinger, O.; Aviram, H.Y.; Riven, I.; Haran, G.; Alfonta, L. In vitro suppression of two different stop codons. Biotechnol. Bioeng. 2017, 114, 1065–1073. [Google Scholar] [CrossRef]
  38. Venkat, S.; Sturges, J.; Stahman, A.; Gregory, C.; Gan, Q.; Fan, C. Genetically Incorporating Two Distinct Post-translational Modifications into One Protein Simultaneously. ACS Synth. Biol. 2018, 7, 689–695. [Google Scholar] [CrossRef]
  39. Wu, B.; Wang, Z.; Huang, Y.; Liu, W.R. Catalyst-Free and Site-Specific One-Pot Dual-Labeling of a Protein Directed by Two Genetically Incorporated Noncanonical Amino Acids. ChemBioChem 2012, 13, 1405–1408. [Google Scholar] [CrossRef] [Green Version]
  40. Blattner, F.R.; Plunkett, G., III; Bloch, C.A.; Perna, N.T.; Burland, V.; Riley, M.; Collado-Vides, J.; Glasner, J.D.; Rode, C.K.; Mayhew, G.F.; et al. The complete genome sequence of Escherichia coli K-12. Science 1997, 277, 1453–1462. [Google Scholar] [CrossRef]
  41. Hayashi, K.; Morooka, N.; Yamamoto, Y.; Fujita, K.; Isono, K.; Choi, S.; Ohtsubo, E.; Baba, T.; Wanner, B.L.; Mori, H.; et al. Highly accurate genome sequences of Escherichia coli K-12 strains MG1655 and W3110. Mol. Syst. Biol. 2006, 2. [Google Scholar] [CrossRef] [PubMed]
  42. Hohsaka, T.; Ashizuka, Y.; Murakami, H.; Sisido, M. Five-base codons for incorporation of nonnatural amino acids into proteins. Nucleic Acids Res. 2001, 29, 3646–3651. [Google Scholar] [CrossRef] [PubMed]
  43. Hohsaka, T.; Ashizuka, Y.; Murakami, H.; Sisido, M. Incorporation of Nonnatural Amino Acids into Streptavidin through In Vitro Frame-Shift Suppression. J. Am. Chem. Soc. 1996, 118, 9778–9779. [Google Scholar] [CrossRef]
  44. Sisido, M.; Hohsaka, T. Introduction of specialty functions by the position-specific incorporation of nonnatural amino acids into proteins through four-base codon/anticodon pairs. Appl. Microbiol. Biotechnol. 2001, 57, 274–281. [Google Scholar] [PubMed]
  45. Mukai, T.; Yamaguchi, A.; Ohtake, K.; Takahashi, M.; Hayashi, A.; Iraha, F.; Kira, S.; Yanagisawa, T.; Yokoyama, S.; Hoshi, H.; et al. Reassignment of a rare sense codon to a non-canonical amino acid in Escherichia coli. NAR 2015, 43, 8111–8122. [Google Scholar] [CrossRef] [PubMed]
  46. Lee, B.S.; Shin, S.; Jeon, J.Y.; Jang, K.; Lee, B.Y.; Choi, S.; Yoo, T.H. Incorporation of Unnatural Amino Acids in Response to the AGG Codon. ACS Chem. Biol. 2015, 10, 1648–1653. [Google Scholar] [CrossRef] [PubMed]
  47. Hohsaka, T.; Sato, K.; Sisido, M.; Takai, K.; Yokoyama, S. Site-specific incorporation of photofunctional nonnatural amino acids into a polypeptide through in vitro protein biosynthesis. FEBS Lett. 1994, 344, 171–174. [Google Scholar] [CrossRef] [Green Version]
  48. Kwok, Y.; Wong, J.T. Evolutionary relationship between Halobacterium cutirubrum and eukaryotes determined by use of aminoacyl-tRNA synthetases as phylogenetic probes. Can. J. Biochem. 1980, 58, 213–218. [Google Scholar] [CrossRef]
  49. Wang, L.; Magliery, T.J.; Liu, D.R.; Schultz, P.G. A New Functional Suppressor tRNA/Aminoacyl-tRNA Synthetase Pair for the in Vivo Incorporation of Unnatural Amino Acids into Proteins. J. Am. Chem. Soc. 2000, 122, 5010–5011. [Google Scholar] [CrossRef]
  50. Benzer, S.; Champe, S.P. A change from nonsense to sense in the genetic code. Proc. Natl. Acad. Sci. USA 1962, 48, 1114–1121. [Google Scholar] [CrossRef]
  51. Garen, A.; Siddiqi, O. Suppression of mutations in the alkaline phosphatase structural cistron of E. coli. Proc. Natl. Acad. Sci. USA 1962, 48, 1121–1127. [Google Scholar] [CrossRef] [PubMed]
  52. Normanly, J.; Kleina, L.G.; Masson, J.M.; Abelson, J.; Miller, J.H. Construction of Escherichia coli amber suppressor tRNA genes. III. Determination of tRNA specificity. J. Mol. Biol. 1990, 213, 719–726. [Google Scholar] [CrossRef]
  53. Fechter, P.; Rudinger-Thirion, J.; Tukalo, M.; Giegé, R. Major tyrosine identity determinants in Methanococcus jannaschii and Saccharomyces cerevisiae tRNATyr are conserved but expressed differently. Eur. J. Biochem. 2001, 268, 761–767. [Google Scholar] [CrossRef] [PubMed]
  54. Steer, B.A.; Schimmel, P. Major anticodon-binding region missing from an archaebacterial tRNA synthetase. J. Biol. Chem. 1999, 274, 35601–35606. [Google Scholar] [CrossRef] [PubMed]
  55. Jakubowski, H.; Goldman, E. Editing of errors in selection of amino acids for protein synthesis. Microbiol. Rev. 1992, 56, 412–429. [Google Scholar] [PubMed]
  56. Wang, L.; Schultz, P.G. A general approach for the generation of orthogonal tRNAs. Chem. Biol. 2001, 8, 883–890. [Google Scholar] [CrossRef] [Green Version]
  57. Wang, L.; Xie, J.; Schultz, P.G. Expanding the genetic code. Annu. Rev. Biophys. Biomol. Struct. 2006, 35, 225–249. [Google Scholar] [CrossRef]
  58. Kobayashi, T.; Nureki, O.; Ishitani, R.; Yaremchuk, A.; Tukalo, M.; Cusack, S.; Sakamoto, K.; Yokoyama, S. Structural basis for orthogonal tRNA specificities of tyrosyl-tRNA synthetases for genetic code expansion. Nat. Struct. Mol. Biol. 2003, 10, 425–432. [Google Scholar] [CrossRef]
  59. Zhang, Y.; Wang, L.; Schultz, P.G.; Wilson, I.A. Crystal structures of apo wild-type M. jannaschii tyrosyl-tRNA synthetase (TyrRS) and an engineered TyrRS specific for O-methyl-L-tyrosine. Protein Sci. 2005, 14, 1340–1349. [Google Scholar] [CrossRef]
  60. Gan, Q.; Lehman, B.P.; Bobik, T.A.; Fan, C. Expanding the genetic code of Salmonella with non-canonical amino acids. Sci. Rep. 2016, 6, 39920. [Google Scholar] [CrossRef]
  61. He, J.; Van Treeck, B.; Nguyen, H.B.; Melançon, C.E. Development of an Unnatural Amino Acid Incorporation System in the Actinobacterial Natural Product Producer Streptomyces venezuelae ATCC 15439. ACS Synth. Biol. 2016, 5, 125–132. [Google Scholar] [CrossRef] [PubMed]
  62. Wang, F.; Robbins, S.; Guo, J.; Shen, W.; Schultz, P.G. Genetic Incorporation of Unnatural Amino Acids into Proteins in Mycobacterium tuberculosis. PLoS ONE 2010, 5, e9354. [Google Scholar] [CrossRef] [PubMed]
  63. Anderson, J.C.; Wu, N.; Santoro, S.W.; Lakshman, V.; King, D.S.; Schultz, P.G. An expanded genetic code with a functional quadruplet codon. Proc. Natl. Acad. Sci. USA 2004, 101, 7566–7571. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  64. Santoro, S.W.; Anderson, J.C.; Lakshman, V.; Schultz, P.G. An archaebacteria-derived glutamyl-tRNA synthetase and tRNA pair for unnatural amino acid mutagenesis of proteins in Escherichia coli. Nucleic Acids Res. 2003, 31, 6700–6709. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  65. Blight, S.K.; Larue, R.C.; Mahapatra, A.; Longstaff, D.G.; Chang, E.; Zhao, G.; Kang, P.T.; Green-Church, K.B.; Chan, M.K.; Krzycki, J.A. Direct charging of tRNA(CUA) with pyrrolysine in vitro and in vivo. Nature 2004, 431, 333–335. [Google Scholar] [CrossRef]
  66. Neumann, H.; Wang, K.; Davis, L.; Garcia-Alai, M.; Chin, J.W. Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome. Nature 2010, 464, 441–444. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  67. Neumann, H.; Peak-Chew, S.Y.; Chin, J.W. Genetically encoding N(epsilon)-acetyllysine in recombinant proteins. Nat. Chem. Biol. 2008, 4, 232–234. [Google Scholar] [CrossRef] [PubMed]
  68. Chatterjee, A.; Xiao, H.; Schultz, P.G. Evolution of multiple, mutually orthogonal prolyl-tRNA synthetase/tRNA pairs for unnatural amino acid mutagenesis in Escherichia coli. Proc. Natl. Acad. Sci. USA 2012, 109, 14841–14846. [Google Scholar] [CrossRef]
  69. Ryu, Y.; Schultz, P.G. Efficient incorporation of unnatural amino acids into proteins in Escherichia coli. Nat. Methods 2006, 3, 263–265. [Google Scholar] [CrossRef]
  70. Camps, M. Modulation of ColE1-like plasmid replication for recombinant gene expression. Recent Pat. DNA Gene Seq. 2010, 4, 58–73. [Google Scholar] [CrossRef]
  71. Plumbridge, J.; Söll, D. The effect of dam methylation on the expression of glnS in E. coli. Biochimie 1987, 69, 539–541. [Google Scholar] [CrossRef]
  72. LaRiviere, F.J.; Wolfson, A.D.; Uhlenbeck, O.C. Uniform binding of aminoacyl-tRNAs to elongation factor Tu by thermodynamic compensation. Science 2001, 294, 165–168. [Google Scholar] [CrossRef] [PubMed]
  73. Park, H.S.; Hohn, M.J.; Umehara, T.; Guo, L.T.; Osborne, E.M.; Benner, J.; Noren, C.J.; Rinehart, J.; Soll, D. Expanding the genetic code of Escherichia coli with phosphoserine. Science 2011, 333, 1151–1154. [Google Scholar] [CrossRef] [PubMed]
  74. Guo, J.; Melancon, C.E., 3rd.; Lee, H.S.; Groff, D.; Schultz, P.G. Evolution of amber suppressor tRNAs for efficient bacterial production of proteins containing nonnatural amino acids. Angew. Chem. Int. Ed. Engl. 2009, 48, 9148–9151. [Google Scholar] [CrossRef] [PubMed]
  75. Young, T.S.; Ahmad, I.; Yin, J.A.; Schultz, P.G. An enhanced system for unnatural amino acid mutagenesis in E. coli. J. Mol. Biol. 2010, 395, 361–374. [Google Scholar] [CrossRef] [PubMed]
  76. Rogerson, D.T.; Sachdeva, A.; Wang, K.; Haq, T.; Kazlauskaite, A.; Hancock, S.M.; Huguenin-Dezot, N.; Muqit, M.M.; Fry, A.M.; Bayliss, R.; et al. Efficient genetic encoding of phosphoserine and its nonhydrolyzable analog. Nat. Chem. Biol. 2015, 11, 496–503. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  77. Chatterjee, A.; Sun, S.B.; Furman, J.L.; Xiao, H.; Schultz, P.G. A versatile platform for single- and multiple-unnatural amino acid mutagenesis in Escherichia coli. Biochemistry 2013, 52, 1828–1837. [Google Scholar] [CrossRef] [PubMed]
  78. Stuitje, A.R.; Spelt, C.E.; Veltkamp, E.; Nijkamp, H.J. Identification of mutations affecting replication control of plasmid Clo DF13. Nature 1981, 290, 264–267. [Google Scholar] [CrossRef] [PubMed]
  79. Amiram, M.; Haimovich, A.D.; Fan, C.; Wang, Y.S.; Aerni, H.R.; Ntai, I.; Moonan, D.W.; Ma, N.J.; Rovner, A.J.; Hong, S.H.; et al. Evolution of translation machinery in recoded bacteria enables multi-site incorporation of nonstandard amino acids. Nat. Biotechnol. 2015, 33, 1272–1279. [Google Scholar] [CrossRef] [Green Version]
  80. Wang, N.; Ju, T.; Niu, W.; Guo, J. Fine-tuning Interaction between Aminoacyl-tRNA Synthetase and tRNA for Efficient Synthesis of Proteins Containing Unnatural Amino Acids. ACS Synth. Biol. 2014, 4, 207–212. [Google Scholar] [CrossRef]
  81. Wang, L.; Zhang, Z.; Brock, A.; Schultz, P.G. Addition of the keto functional group to the genetic code of Escherichia coli. Proc. Natl. Acad. Sci. USA 2003, 100, 56–61. [Google Scholar] [CrossRef] [PubMed]
  82. Chin, J.W.; Martin, A.B.; King, D.S.; Wang, L.; Schultz, P.G. Addition of a photocrosslinking amino acid to the genetic code of Escherichiacoli. Proc. Natl. Acad. Sci. USA 2002, 99, 11020–11024. [Google Scholar] [CrossRef] [PubMed]
  83. Liu, C.C.; Schultz, P.G. Recombinant expression of selectively sulfated proteins in Escherichia coli. Nat. Biotechnol. 2006, 24, 1436–1440. [Google Scholar] [CrossRef] [PubMed]
  84. Singh, V.; Braddick, D. Recent advances and versatility of MAGE towards industrial applications. Syst. Synth. Biol. 2015, 9, 1–9. [Google Scholar] [CrossRef] [Green Version]
  85. Bryson, D.I.; Fan, C.; Guo, L.; Miller, C.; Soll, D.; Liu, D.R. Continuous directed evolution of aminoacyl-tRNA synthetases. Nat. Chem. Biol. 2017, 13, 1253. [Google Scholar] [CrossRef] [PubMed]
  86. Badran, A.H.; Liu, D.R. Development of potent in vivo mutagenesis plasmids with broad mutational spectra. Nat. Commun. 2015, 6, 8425. [Google Scholar] [CrossRef] [PubMed]
  87. Doi, Y.; Ohtsuki, T.; Shimizu, Y.; Ueda, T.; Sisido, M. Elongation factor Tu mutants expand amino acid tolerance of protein biosynthesis system. J. Am. Chem. Soc. 2007, 129, 14458–14462. [Google Scholar] [CrossRef] [PubMed]
  88. Ohtsuki, T.; Yamamoto, H.; Doi, Y.; Sisido, M. Use of EF-Tu mutants for determining and improving aminoacylation efficiency and for purifying aminoacyl tRNAs with non-natural amino acids. J. Biochem. 2010, 148, 239–246. [Google Scholar] [CrossRef]
  89. Gan, R.; Perez, J.G.; Carlson, E.D.; Ntai, I.; Isaacs, F.J.; Kelleher, N.L.; Jewett, M.C. Translation system engineering in Escherichia coli enhances non-canonical amino acid incorporation into proteins. Biotechnol. Bioeng. 2017, 114, 1074–1086. [Google Scholar] [CrossRef]
  90. Fan, C.; Ip, K.; Soll, D. Expanding the genetic code of Escherichia coli with phosphotyrosine. FEBS Lett. 2016, 590, 3040–3047. [Google Scholar] [CrossRef]
  91. Rackham, O.; Chin, J.W. A network of orthogonal ribosome x mRNA pairs. Nat. Chem. Biol. 2005, 1, 159–166. [Google Scholar] [CrossRef] [PubMed]
  92. Wang, K.; Neumann, H.; Peak-Chew, S.Y.; Chin, J.W. Evolved orthogonal ribosomes enhance the efficiency of synthetic genetic code expansion. Nat. Biotechnol. 2007, 25, 770–777. [Google Scholar] [CrossRef] [PubMed]
  93. Thyer, R.; Filipovska, A.; Rackham, O. Engineered rRNA enhances the efficiency of selenocysteine incorporation during translation. J. Am. Chem. Soc. 2013, 135, 2–5. [Google Scholar] [CrossRef] [PubMed]
  94. Dedkova, L.M.; Fahmi, N.E.; Golovine, S.Y.; Hecht, S.M. Enhanced D-amino acid incorporation into protein by modified ribosomes. J. Am. Chem. Soc. 2003, 125, 6616–6617. [Google Scholar] [CrossRef] [PubMed]
  95. Dedkova, L.M.; Fahmi, N.E.; Paul, R.; del Rosario, M.; Zhang, L.; Chen, S.; Feder, G.; Hecht, S.M. beta-Puromycin selection of modified ribosomes for in vitro incorporation of beta-amino acids. Biochemistry 2012, 51, 401–415. [Google Scholar] [CrossRef] [PubMed]
  96. Maini, R.; Nguyen, D.T.; Chen, S.; Dedkova, L.M.; Chowdhury, S.R.; Alcala-Torano, R.; Hecht, S.M. Incorporation of beta-amino acids into dihydrofolate reductase by ribosomes having modifications in the peptidyltransferase center. Bioorg. Med. Chem. 2013, 21, 1088–1096. [Google Scholar] [CrossRef] [PubMed]
  97. Terasaka, N.; Hayashi, G.; Katoh, T.; Suga, H. An orthogonal ribosome-tRNA pair via engineering of the peptidyl transferase center. Nat. Chem. Biol. 2014, 10, 555–557. [Google Scholar] [CrossRef] [PubMed]
  98. Orelle, C.; Carlson, E.D.; Szal, T.; Florin, T.; Jewett, M.C.; Mankin, A.S. Protein synthesis by ribosomes with tethered subunits. Nature 2015, 524, 119–124. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  99. Fried, S.D.; Schmied, W.H.; Uttamapinant, C.; Chin, J.W. Ribosome Subunit Stapling for Orthogonal Translation in E. coli. Angew. Chem. Int. Ed. Engl. 2015, 54, 12791–12794. [Google Scholar] [CrossRef]
  100. Scolnick, E.; Tompkins, R.; Caskey, T.; Nirenberg, M. Release factors differing in specificity for terminator codons. Proc. Natl. Acad. Sci. USA 1968, 61, 768–774. [Google Scholar] [CrossRef]
  101. Short, G.F., 3rd.; Golovine, S.Y.; Hecht, S.M. Effects of release factor 1 on in vitro protein translation and the elaboration of proteins containing unnatural amino acids. Biochemistry 1999, 38, 8808–8819. [Google Scholar] [CrossRef] [PubMed]
  102. Wang, Y.S.; Russell, W.K.; Wang, Z.; Wan, W.; Dodd, L.E.; Pai, P.J.; Russell, D.H.; Liu, W.R. The de novo engineering of pyrrolysyl-tRNA synthetase for genetic incorporation of L-phenylalanine and its derivatives. Mol. Biosyst. 2011, 7, 714–717. [Google Scholar] [CrossRef] [PubMed]
  103. Johnson, D.B.; Xu, J.; Shen, Z.; Takimoto, J.K.; Schultz, M.D.; Schmitz, R.J.; Xiang, Z.; Ecker, J.R.; Briggs, S.P.; Wang, L. RF1 knockout allows ribosomal incorporation of unnatural amino acids at multiple sites. Nat. Chem. Biol. 2011, 7, 779–786. [Google Scholar] [CrossRef] [PubMed] [Green Version]
  104. Ryden, S.; Isaksson, L. A temperature-sensitive mutant of Escherichia coli that shows enhanced misreading of UAG/A and increased efficiency for tRNA nonsense suppressors. Mol. Gen. Genet. MGG 1984, 193, 38–45. [Google Scholar] [CrossRef] [PubMed]
  105. Jackson, D.Y.; Burnier, J.; Quan, C.; Stanley, M.; Tom, J.; Wells, J.A. A designed peptide ligase for total synthesis of ribonuclease A with unnatural catalytic residues. Science 1994, 266, 243–247. [Google Scholar] [CrossRef] [PubMed]
  106. Posfai, G.; Plunkett, G., 3rd.; Feher, T.; Frisch, D.; Keil, G.M.; Umenhoffer, K.; Kolisnychenko, V.; Stahl, B.; Sharma, S.S.; de Arruda, M.; et al. Emergent properties of reduced-genome Escherichia coli. Science 2006, 312, 1044–1046. [Google Scholar] [CrossRef] [PubMed]
  107. Ohtake, K.; Sato, A.; Mukai, T.; Hino, N.; Yokoyama, S.; Sakamoto, K. Efficient decoding of the UAG triplet as a full-fledged sense codon enhances the growth of a prfA-deficient strain of Escherichia coli. J. Bacteriol. 2012, 194, 2606–2613. [Google Scholar] [CrossRef] [PubMed]
  108. Mukai, T.; Hayashi, A.; Iraha, F.; Sato, A.; Ohtake, K.; Yokoyama, S.; Sakamoto, K. Codon reassignment in the Escherichia coli genetic code. Nucleic Acids Res. 2010, 38, 8188–8195. [Google Scholar] [CrossRef] [Green Version]
  109. Heinemann, I.U.; Rovner, A.J.; Aerni, H.R.; Rogulina, S.; Cheng, L.; Olds, W.; Fischer, J.T.; Söll, D.; Isaacs, F.J.; Rinehart, J. Enhanced phosphoserine insertion during Escherichia coli protein synthesis via partial UAG codon reassignment and release factor 1 deletion. FEBS Lett. 2012, 586, 3716–3722. [Google Scholar] [CrossRef]
  110. Mukai, T.; Hoshi, H.; Ohtake, K.; Takahashi, M.; Yamaguchi, A.; Hayashi, A.; Yokoyama, S.; Sakamoto, K. Highly reproductive Escherichia coli cells with no specific assignment to the UAG codon. Sci. Rep. 2015, 5, 9699. [Google Scholar] [CrossRef]
  111. Lajoie, M.J.; Rovner, A.J.; Goodman, D.B.; Aerni, H.R.; Haimovich, A.D.; Kuznetsov, G.; Mercer, J.A.; Wang, H.H.; Carr, P.A.; Mosberg, J.A.; et al. Genomically recoded organisms expand biological functions. Science 2013, 342, 357–360. [Google Scholar] [CrossRef] [PubMed]
  112. Zheng, Y.; Lajoie, M.J.; Italia, J.S.; Chin, M.A.; Church, G.M.; Chatterjee, A. Performance of optimized noncanonical amino acid mutagenesis systems in the absence of release factor 1. Mol. Biosyst. 2016, 12, 1746–1749. [Google Scholar] [CrossRef] [PubMed]
  113. Jin, X.; Park, O.J.; Hong, S.H. Incorporation of non-standard amino acids into proteins: Challenges, recent achievements, and emerging applications. Appl. Microbiol. Biotechnol. 2019, 103, 2947–2958. [Google Scholar] [CrossRef] [PubMed]
  114. Luo, X.; Fu, G.; Wang, R.E.; Zhu, X.; Zambaldo, C.; Liu, R.; Liu, T.; Lyu, X.; Du, J.; Xuan, W.; et al. Genetically encoding phosphotyrosine and its nonhydrolyzable analog in bacteria. Nat. Chem. Biol. 2017, 13, 845. [Google Scholar] [CrossRef] [PubMed]
  115. Ko, W.; Kumar, R.; Kim, S.; Lee, H.S. Construction of Bacterial Cells with an Active Transport System for Unnatural Amino Acids. ACS Synth. Biol. 2019, 8, 1195–1203. [Google Scholar] [CrossRef] [PubMed]
  116. Crnkovic, A.; Vargas-Rodriguez, O.; Merkuryev, A.; Soll, D. Effects of Heterologous tRNA Modifications on the Production of Proteins Containing Noncanonical Amino Acids. Bioengineering 2018, 5, 11. [Google Scholar] [CrossRef] [PubMed]
  117. Hofnung, M.; Bedouelle, H.; Boulain, J.; Clement, J.; Charbit, A.; Duplay, P.; Gehring, K.; Martineau, P.; Saurin, W.; Szmelcman, S. Genetic approaches to the study and use of proteins: Random point mutations and random linker insertions. Bull. Inst. Pasteur 1988, 86, 95–101. [Google Scholar]
  118. Chemla, Y.; Ozer, E.; Algov, I.; Alfonta, L. Context effects of genetic code expansion by stop codon suppression. Curr. Opin. Chem. Biol. 2018, 46, 146–155. [Google Scholar] [CrossRef] [PubMed]
  119. Zhang, Y.; Ptacin, J.L.; Fischer, E.C.; Aerni, H.R.; Caffaro, C.E.; San Jose, K.; Feldman, A.W.; Turner, C.R.; Romesberg, F.E. A semi-synthetic organism that stores and retrieves increased genetic information. Nature 2017, 551, 644–647. [Google Scholar] [CrossRef] [PubMed] [Green Version]
Biomolecules 09 00255 g001 550
Figure 1. Schematic representation of expanded genetic code methodology. (a) Translation in E. coli cell: Endogenous aminoacyl-tRNA synthetases (aa-RS) (designed by cyan) charge tRNA (black colour) with cognate amino acids and aminoacyl-tRNA is transferred by elongation factor Tu (EF-Tu) to the ribosome. Proper interaction of mRNA codon and tRNA is required for the release of EF-Tu and peptide bond formation; (b) the methodology of genetic code expansion: NAA incorporation in response to amber stop codon is provided by supplying the organism with orthogonal aa-RS (violet colour) and suppressor tRNA (red colour). Suppressor tRNA is in competition with class I release factor (RF1).
Figure 1. Schematic representation of expanded genetic code methodology. (a) Translation in E. coli cell: Endogenous aminoacyl-tRNA synthetases (aa-RS) (designed by cyan) charge tRNA (black colour) with cognate amino acids and aminoacyl-tRNA is transferred by elongation factor Tu (EF-Tu) to the ribosome. Proper interaction of mRNA codon and tRNA is required for the release of EF-Tu and peptide bond formation; (b) the methodology of genetic code expansion: NAA incorporation in response to amber stop codon is provided by supplying the organism with orthogonal aa-RS (violet colour) and suppressor tRNA (red colour). Suppressor tRNA is in competition with class I release factor (RF1).
Biomolecules 09 00255 g001
Biomolecules 09 00255 g002 550
Figure 2. Scheme of nonsense (a), sense (b) and frame-shift (c) suppression demonstrates the interaction of mRNA with orthogonal tRNA.
Figure 2. Scheme of nonsense (a), sense (b) and frame-shift (c) suppression demonstrates the interaction of mRNA with orthogonal tRNA.
Biomolecules 09 00255 g002
Biomolecules 09 00255 g003 550
Figure 3. Improved orthogonal translation system includes aa-RS with enhanced enzymatic efficiency, optimized tRNA and evolved EF-Tu (shown by blue colour). Moreover, the overall efficiency of nonsense suppression is achieved due to the sequestration of RF1 from the translation process by application of orthogonal mRNA and 30S orthogonal ribosome subunit or by exploiting genetically recoded E. coli lacking RF1.
Figure 3. Improved orthogonal translation system includes aa-RS with enhanced enzymatic efficiency, optimized tRNA and evolved EF-Tu (shown by blue colour). Moreover, the overall efficiency of nonsense suppression is achieved due to the sequestration of RF1 from the translation process by application of orthogonal mRNA and 30S orthogonal ribosome subunit or by exploiting genetically recoded E. coli lacking RF1.
Biomolecules 09 00255 g003

Share and Cite

MDPI and ACS Style

Smolskaya, S.; Andreev, Y.A. Site-Specific Incorporation of Unnatural Amino Acids into Escherichia coli Recombinant Protein: Methodology Development and Recent Achievement. Biomolecules 2019, 9, 255. https://doi.org/10.3390/biom9070255

AMA Style

Smolskaya S, Andreev YA. Site-Specific Incorporation of Unnatural Amino Acids into Escherichia coli Recombinant Protein: Methodology Development and Recent Achievement. Biomolecules. 2019; 9(7):255. https://doi.org/10.3390/biom9070255

Chicago/Turabian Style

Smolskaya, Sviatlana, and Yaroslav A. Andreev. 2019. "Site-Specific Incorporation of Unnatural Amino Acids into Escherichia coli Recombinant Protein: Methodology Development and Recent Achievement" Biomolecules 9, no. 7: 255. https://doi.org/10.3390/biom9070255

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop